• NORTH CAROLINA SOCIETY OF GASTROENTEROLOGY
  • 704.376.3688
  • sbuchanan@meckmed.org
NCSGlogo-300NCSGlogo-only-150NCSGlogo-300NCSGlogo-300
  • Home
  • Events and Education
  • Research
  • About NCSG
    • Board of Directors
    • Board Meetings
    • Grants
    • Partners
    • NCSG Bylaws
JOIN or RENEW HERE
✕
Categories
  • Ulcerative Colitis
Tags
  • Ulcerative Colitis
Study title Phase 1, Open Label, Drug Interaction Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants with Moderate to Severe Crohn’s Disease and Ulcerative Colitis
Disease or condition Ulcerative colitis and Crohn’s disease
Study type Pharmacokinetic study (all receive Ustekinumab)
Intervention/treatment Ustekinumab
Phase 1
Study site Duke University
Study location Durham
Principal investigator Jane Onken
Study coordinator Jane Stiles  janev.stiles@duke.edu
Phone contact 919-684-1329
Clinicaltrials.gov link https://clinicaltrials.gov/ct2/show/NCT03358706

ADDRESS


1112 Harding Place
Suite 100
Charlotte NC 28204

Fax: 704.376.3173

LINKS


Home
Education
Events
Research
JOIN NOW

CONTACT


704.376.3688
sbuchanan@meckmed.org

Copyright: North Carolina Society of Gastroenterology (NCSG)
JOIN or RENEW HERE